(Q52021821)

19 April 2018

title

Effects of long-term administration of low-dose lactitol in patients with cirrhosis but without overt encephalopathy. (English)

1 reference

19 April 2018

author name string

F Salerno

1

1 reference

19 April 2018

P Moser

2

1 reference

19 April 2018

A Maggi

3

1 reference

19 April 2018

G Vitaliani

4

1 reference

19 April 2018

G Benetti

5

1 reference

19 April 2018

publication date

1 December 1994

1 reference

19 April 2018

published in

Journal of Hepatology

1 reference

19 April 2018

volume

21

1 reference

19 April 2018

issue

6

1 reference

19 April 2018

page(s)

1092-1096

1 reference

19 April 2018

Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980623-3

7 January 2021

Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980623-3

7 January 2021

Lactitol vs. lactulose in the treatment of chronic recurrent portal-systemic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980623-3

7 January 2021

Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980623-3

7 January 2021

Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980623-3

7 January 2021

Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal-systemic shunt

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980623-3

7 January 2021

Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980623-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980623-3

7 January 2021

The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980623-3

7 January 2021

Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980623-3

7 January 2021

Effect of dietary protein manipulation in subclinical portal-systemic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980623-3

7 January 2021

Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980623-3

7 January 2021

Branched-chain amino acids in the treatment of chronic hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980623-3

7 January 2021

Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980623-3

7 January 2021

Treatment of chronic portal--systemic encephalopathy with vegetable and animal protein diets. A controlled crossover study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980623-3

7 January 2021

Comparison of animal and vegetable protein sources in the dietary management of hepatic encephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980623-3

7 January 2021

10.1016/S0168-8278(05)80623-3

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018